AI-powered precision: Unlocking the future of immunotherapy through immunogenomics, radiomics, and pathomics
Peer-Reviewed Publication
Updates every hour. Last Updated: 5-Aug-2025 12:11 ET (5-Aug-2025 16:11 GMT/UTC)
Led by Alex Zhavoronkov, Ph.D, founder and co-CEO of Insilico Medicine, Sujata Rao, M.D, Chief Medical Officer, Michelle Chen, Ph.D, Chief Business Officer, and Carol Satler, M.D, PhD, SVP of Clinical Development, the experienced Insilico team will be welcoming collaboration and clinical insight conversations at Booth #1464, Halls ABC Moscone Center.
A research paper by scientists at Peking University Third Hospital presented a study on the regulatory mechanisms of the ECS in the substantia nigra (SN) of PD rats following STN-DBS.A research paper by scientists at Peking University Third Hospital presented a study on the regulatory mechanisms of the ECS in the substantia nigra (SN) of PD rats following STN-DBS.
A new study published in the Journal of Studies on Alcohol and Drugs reveals important differences in the reach of collegiate recovery programs (CRPs), based on the number of the programs' funding sources. CRPs that had multiple funding sources served twice as many students as CRPs that relied on only a single source. These programs were also more likely to provide dedicated space and relapse management support to students. All Recovery meetings, which are inclusive support groups open to people exploring different forms of recovery and in all stages of the recovery process, were the most common type of mutual-aid support groups in CRPs.
The May issue of Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology, explores the mental health burden these conditions can exact, and how allergists can help.